25 results for “tumor”. Showing 25 of 39,449.
Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.
tumors in relation to tumor grade. MSMB levels are also
NPM1 inhibits tumoral antigen presentation to promote immune evasion and tumor progression.
tumor cells. CONCLUSIONS: Tumor-intrinsic NPM1 promotes tumor immune evasion
Neutrophils Restrict Tumor-Associated Microbiota to Reduce Growth and Invasion of Colon Tumors in Mice.
tumors and proliferation of tumor cells, tumor-cell DNA damage
Chondrogenic Bone Tumors: The Importance of Imaging Characteristics.
tumors. · Frequent benign tumors: osteochondroma and enchondroma; Frequent malignant tumor
Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity.
tumors) or subcutaneously in flank skin (secondary tumors). Changes to the tumor
[Identification and single-cell sequencing analysis of rare tumor cells in malignant pleural effusion of lung cancer patients].
Tumor heterogeneity refers to distinct genomic or phenotypic characteristics of tumor
Glioblastoma Neurovascular Progenitor Orchestrates Tumor Cell Type Diversity.
tumor with limited treatment options. Recent studies have profiled GBM tumor
Mammary tumors alter the fecal bacteriome and permit enteric bacterial translocation.
tumor recipients, and tumor recipients later receiving tumor-resection. Mice
Primary undifferentiated spindle cell sarcoma of the lung with metastasis to bone - A rare clinical entity with even rarer clinical course
tumor cells, with areas of necrosis. Immunohistochemically, the tumor cells
Characterization of anti-tumor networks in tumor-associated macrophages 2377
Tumor-associated macrophages (TAMs) have been shown to compose up to 50% of a tumor
Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations.
tumors and adjacent lung tissues. Within tumors, accompanied by an increase
Piezo channels in tumors.
tumors currently pose a significant threat to global health. Tumor
Molecular and Circulating Biomarkers of Brain Tumors.
tumor tissue. Tumor-derived biomarkers include nucleic acids, proteins, and tumor
Original Articles: Testis Cancer: A Review of Scrotal Violation in Testicular Cancer: Is Adjuvant Local Therapy Necessary?
tumor: the clinical significance of the tumor-contaminated scrotum. J. Urol.1984
Chemotherapy delivery issues in central nervous system malignancy: a reality check.
tumor chemotherapy and evaluates relevant brain tumor pharmacology studies before
CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4.
tumor killing. Mechanistically, IFNγ stimulates ACSL4 and alters tumor cell
Choroid plexus tumor necrosis factor receptor 1: A new neuroinflammatory piece of the complex Alzheimer's disease puzzle.
tumor necrosis factor receptor 1 and tumor necrosis factor receptor
A brain-tumor neural circuit controls breast cancer progression in mice.
tumor progression via nerve-tumor crosstalk in a mouse model
Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors.
tumors. A significant proportion of CNS tumors are now well
Tumor-Infiltrating Clonal Hematopoiesis.
tumors, a phenomenon we term tumor-infiltrating clonal hematopoiesis (TI-CH). The frequency
Mapping pediatric brain tumors to their origins in the developing cerebellum.
tumors is key for understanding tumor initiation and identifying lineage
HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants.
tumor-expressed antigens by cytotoxic CD8+ T cells is the foundation
TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer.
tumor immunity, but its role in tumor vasculature is unclear
Navigating the management of follicular variant papillary thyroid carcinoma subtypes: a classic PTC comparison.
tumors, infiltrative fvPTC tumors have aggressive clinicopathologic features and thus
Tumor biomarkers for diagnosis, prognosis and targeted therapy.
Tumor biomarkers, the substances which are produced by tumors or the body